Despite increased orders and the public’s unprecedented rush to get vaccinated, influenza vaccination rates did not increase during the fall and winter of 2020-2021—in fact, the numbers are down in most of the age groups measured.
Sanofi will build a new vaccine manufacturing facility in Toronto, Ontario, to increase the supply of its Fluzone High-Dose quadrivalent influenza vaccine in Canada, the U.S. and Europe.